Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
Historically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics in sub-Saharan Africa. In 2010, Burkina Faso became the first country to implement a national meningococcal serogroup A conjugate vaccine (MACV) campaign. We analyzed nationwide meningitis surveillance data from...
Main Authors: | Alpha Oumar Diallo, Heidi M Soeters, Issaka Yameogo, Guetawendé Sawadogo, Flavien Aké, Clément Lingani, Xin Wang, Andre Bita, Amadou Fall, Lassana Sangaré, Rasmata Ouédraogo-Traoré, Isaïe Medah, Brice Bicaba, Ryan T Novak, MenAfriNet Consortium |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5667755?pdf=render |
Similar Items
-
Effects of MenAfriVac® Introduction in the African Meningitis Belt, 2010-2017
by: Bita Fouda, Andre Arsene
Published: (2018) -
Meningococcal serogroup A and tetanus immunity two years after MenAfriVac™ introduction in Mali
by: N.E. Basta, et al.
Published: (2014-04-01) -
Effects of MenAfriVac(RTM) Introduction in the African Meningitis Belt, 2010--2017
by: Bita Fouda, Andre Arsene
Published: (2019) -
Understanding the Role of Duration of Vaccine Protection with MenAfriVac: Simulating Alternative Vaccination Strategies
by: Andromachi Karachaliou Prasinou, et al.
Published: (2021-02-01) -
Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine
by: Guro K. Bårnes, et al.
Published: (2016-11-01)